Skip to main content
Robert Lober, MD, Neurosurgery, Dayton, OH

RobertMichaelLoberMD

Neurosurgery Dayton, OH

Pediatric Neurosurgery

Physician

Dr. Lober is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lober's full profile

Already have an account?

  • Office

    1 Childrens Plz
    Dayton, OH 45404
    Phone+1 937-641-4000
    Fax+1 937-641-4500

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Neurosurgery, 2014 - 2015
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Neurological Surgery, 2008 - 2015
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Neuro-Oncology, 2011 - 2012
  • Stanford Health Care
    Stanford Health CareInternship, Transitional Year, 2008 - 2009
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2008

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2015 - 2026
  • CA State Medical License
    CA State Medical License 2009 - 2025
  • American Board of Neurological Surgery Neurological Surgery

Publications & Presentations

PubMed

Press Mentions

  • Myrtelle Announces Positive Data for Its Investigational Proprietary rAAV-Olig001-ASPA Gene Therapy in Canavan Disease at the National Tay Sachs & Allied Diseases Association Conference
    Myrtelle Announces Positive Data for Its Investigational Proprietary rAAV-Olig001-ASPA Gene Therapy in Canavan Disease at the National Tay Sachs & Allied Diseases Association ConferenceJuly 8th, 2022
  • Myrtelle Announces Positive Preliminary Clinical Data for Its Proprietary Gene Therapy in Canavan Disease
    Myrtelle Announces Positive Preliminary Clinical Data for Its Proprietary Gene Therapy in Canavan DiseaseFebruary 15th, 2022
  • New Gene Therapy Trial in US Offers Hope for Children with Canavan Disease
    New Gene Therapy Trial in US Offers Hope for Children with Canavan DiseaseMay 8th, 2021
  • Join now to see all

Grant Support

  • GPCR Lateral Membrane Diffusion In Neuronal SignalingNational Institute Of Neurological Disorders And Stroke2006–2008

Professional Memberships